TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Prostate Cancer Nuclear Medicine Diagnostics Market – By Type
1.3.2 APAC Prostate Cancer Nuclear Medicine Diagnostics Market – By PET Product
1.3.3 APAC Prostate Cancer Nuclear Medicine Diagnostics Market – By End User
1.3.4 APAC Prostate Cancer Nuclear Medicine Diagnostics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Prostate Cancer Nuclear Medicine Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 APAC PEST Analysis
4.3 Experts Opinion
5. APAC Prostate Cancer Nuclear Medicine Diagnostics Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Developing Prevalence of Prostate Cancer
5.1.2 Growing Demand for Early and Precise Diagnosis of Prostate Cancer
5.2 Market Restraints
5.2.1 High Price Related to the Prostate Cancer Diagnostics and Treatment
5.3 Market Opportunities
5.3.1 Increasing Use of Radiopharmaceuticals in Prostate Cancer
5.4 Future Trends
5.4.1 Growing Research Activities for Development of Innovative Imaging Agents
5.5 Impact Analysis
6. Prostate Cancer Nuclear Medicine Diagnostics Market– APAC Analysis
6.1 APAC Prostate Cancer Nuclear Medicine Diagnostics Market Revenue Forecast and Analysis
7. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Analysis – By Type
7.1 Overview
7.2 APAC Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2022 & 2028 (%)
7.3 SPECT
7.3.1 Overview
7.3.2 SPECT: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 PET
7.4.1 Overview
7.4.2 PET: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
8. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Analysis – By PET Product
8.1 Overview
8.2 APAC Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2022 & 2028 (%)
8.3 F-18
8.3.1 Overview
8.3.2 F-18: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 C-11
8.4.1 Overview
8.4.2 C-11: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 GA 68 PSMA
8.5.1 Overview
8.5.2 GA 68 PSMA: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. APAC Prostate Cancer Nuclear Medicine Diagnostics Market – By End User
9.1 Overview
9.2 APAC Prostate Cancer Nuclear Medicine Diagnostics Market Share by End User- 2022 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Clinics
9.4.1 Overview
9.4.2 Clinics: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. APAC Prostate Cancer Nuclear Medicine Diagnostics Market – By Country Analysis
10.1 APAC: Prostate Cancer Nuclear Medicine Diagnostics Market
10.1.1 Overview
10.1.2 APAC: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2022 & 2028 (%)
10.1.2.1 China: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 China: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 China: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2019–2028 (US$ Million)
10.1.2.1.4 China: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2019–2028 (US$ Million)
10.1.2.1.5 China: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ million)
10.1.2.2 Japan: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Japan: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Japan: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2019–2028 (US$ Million)
10.1.2.2.4 Japan: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2019–2028 (US$ Million)
10.1.2.2.5 Japan: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ million)
10.1.2.3 India: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 India: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 India: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2019–2028 (US$ Million)
10.1.2.3.4 India: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2019–2028 (US$ Million)
10.1.2.3.5 India: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ million)
10.1.2.4 Australia: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 Australia: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.3 Australia: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2019–2028 (US$ Million)
10.1.2.4.4 Australia: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2019–2028 (US$ Million)
10.1.2.4.5 Australia: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ million)
10.1.2.5 South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.1 Overview
10.1.2.5.2 South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.3 South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2019–2028 (US$ Million)
10.1.2.5.4 South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2019–2028 (US$ Million)
10.1.2.5.5 South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ million)
10.1.2.6 Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.3 Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2019–2028 (US$ Million)
10.1.2.6.4 Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2019–2028 (US$ Million)
10.1.2.6.5 Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ million)
11. Prostate Cancer Nuclear Medicine Diagnostics Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market, 2021-2028
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 ImaginAb
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Curium
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Jubilant Radiopharma
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 ABX advanced biochemical compounds GmbH
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Telix Pharmaceuticals Ltd.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Novartis AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Lantheus Medical Imaging, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES.
Table 1. China: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. China: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product– Revenue and Forecast to 2028 (US$ Million)
Table 3. China Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ million)
Table 4. Japan: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. Japan: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product– Revenue and Forecast to 2028 (US$ Million)
Table 6. Japan: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ million)
Table 7. India: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type– Revenue and Forecast to 2028 (US$ Million)
Table 8. India: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product– Revenue and Forecast to 2028 (US$ Million)
Table 9. India Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ million)
Table 10. Australia: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. Australia: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product – Revenue and Forecast to 2028 (US$ Million)
Table 12. Australia Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ million)
Table 13. South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product – Revenue and Forecast to 2028 (US$ Million)
Table 15. South Korea Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ million)
Table 16. Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product – Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Asia Pacific Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ million)
Table 19. Recent Inorganic Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market
Table 20. Recent Organic Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market
Table 21. Glossary of Terms, Prostate Cancer Nuclear Medicine Diagnostics Market
LIST OF FIGURES.
Figure 1. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Segmentation
Figure 2. APAC Prostate Cancer Nuclear Medicine Diagnostics Market, By Country
Figure 3. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Overview
Figure 4. PET Segment Held Largest Share of Type Segment in Prostate Cancer Nuclear Medicine Diagnostics Market
Figure 5. China is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. APAC: PEST Analysis
Figure 7. APAC Experts Opinion
Figure 8. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Impact Analysis of Drivers and Restraints
Figure 9. APAC Prostate Cancer Nuclear Medicine Diagnostics Market– Revenue Forecast and Analysis – 2022 - 2028
Figure 10. APAC Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2022 & 2028 (%)
Figure 11. APAC SPECT: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. APAC PET: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. APAC Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product, 2022 & 2028 (%)
Figure 14. APAC F-18: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 15. APAC C-11: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 16. APAC GA 68 PSMA: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 17. APAC Prostate Cancer Nuclear Medicine Diagnostics Market Share by End User - 2022 & 2028 (%)
Figure 18. APAC Hospitals: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 19. APAC Clinics: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 20. APAC Others: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21. APAC: Prostate Cancer Nuclear Medicine Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 22. APAC: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2022 & 2028 (%)
Figure 23. China: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Japan: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. India: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Australia: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. South Korea: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Rest of Asia Pacific: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market, 2021-2028